Sarepta Therapeutics (SRPT) Capital Expenditures (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.05% |
| Dec 31, 2025 | -84.34% |
| Sep 30, 2025 | -27.87% |
| Jun 30, 2025 | -27.16% |
| Mar 31, 2025 | 14.62% |
| Dec 31, 2024 | 2.20% |
| Sep 30, 2024 | 27.76% |
| Jun 30, 2024 | -10.10% |
| Mar 31, 2024 | 70.41% |
| Dec 31, 2023 | -35.84% |
| Sep 30, 2023 | 65.69% |
| Jun 30, 2023 | 88.81% |
| Mar 31, 2023 | 19.10% |
| Dec 31, 2022 | -3.24% |
| Sep 30, 2022 | -9.33% |
| Jun 30, 2022 | 63.54% |
| Mar 31, 2022 | 151.63% |
| Dec 31, 2021 | -76.13% |
| Sep 30, 2021 | 56.79% |
| Jun 30, 2021 | -72.13% |
| Mar 31, 2021 | -26.08% |
| Dec 31, 2020 | 13.07% |
| Sep 30, 2020 | 32.00% |
| Jun 30, 2020 | 110.19% |
| Mar 31, 2020 | -47.15% |
| Dec 31, 2019 | 83.02% |
| Sep 30, 2019 | -43.48% |
| Jun 30, 2019 | 2.58% |
| Mar 31, 2019 | -19.50% |
| Dec 31, 2018 | 0.56% |
| Sep 30, 2018 | 131.01% |
| Jun 30, 2018 | -28.51% |
| Mar 31, 2018 | 212.03% |
| Dec 31, 2017 | 409.67% |
| Sep 30, 2017 | -73.35% |
| Jun 30, 2017 | -35.70% |
| Mar 31, 2017 | 53.23% |
| Dec 31, 2016 | 246.90% |
| Sep 30, 2016 | 100.48% |
| Jun 30, 2016 | -64.13% |
| Mar 31, 2016 | 7.65% |
| Dec 31, 2015 | -5.41% |
| Sep 30, 2015 | 80.06% |
| Jun 30, 2015 | 19.74% |
| Mar 31, 2015 | -83.05% |
| Dec 31, 2014 | -74.82% |
| Sep 30, 2014 | 176.06% |
| Jun 30, 2014 | -15.23% |
| Mar 31, 2014 | 775.99% |
| Dec 31, 2013 | -54.18% |
| Sep 30, 2013 | 211.50% |
| Jun 30, 2013 | 4,633.33% |
| Sep 30, 2012 | -126.12% |
| Jun 30, 2012 | 1,388.89% |
| Mar 31, 2012 | -95.61% |
| Dec 31, 2011 | -30.98% |
| Sep 30, 2011 | -33.85% |
| Jun 30, 2011 | 97.80% |
| Mar 31, 2011 | 11.27% |
| Dec 31, 2010 | -29.17% |